Cystic fibrosis
RecruitingStudy on the Safety and Effects of SPL84 for Patients with Cystic Fibrosis
- Disease:Cystic fibrosis
- Substances:–
Czechia- Participants:18–64 years · 65+ years
- Sponsor:Splisense Ltd.
Rare diseases
Investigational molecules
Locations

Minrav Bldg, Floor 1st, Haddasah Ein Karem, 9112101
Research activity is centered on cystic fibrosis, with attention to the underlying genetic and respiratory dimensions of the disease. The clinical focus includes treatment strategies intended for patients living with chronic airway disease and inherited pulmonary dysfunction.
Clinical interest extends to therapies designed for inhaled delivery in the management of respiratory symptoms associated with this condition.
Splisense Ltd. runs clinical trials in conditions such as Cystic fibrosis, among others.
Clinical trials run by this sponsor – those enrolling participants first.
CzechiaIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.